| Year |
Citation |
Score |
| 2023 |
Chapman OS, Luebeck J, Sridhar S, Wong IT, Dixit D, Wang S, Prasad G, Rajkumar U, Pagadala MS, Larson JD, He BJ, Hung KL, Lange JT, Dehkordi SR, Chandran S, et al. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma. Nature Genetics. PMID 37945900 DOI: 10.1038/s41588-023-01551-3 |
0.324 |
|
| 2020 |
Dunphy PS, Xu K, Gentry DT, He C, Mercer K, Zhu X, Smith K, Gudenas B, Robinson S, Zhang J, Kasper LH, Kwon C, Hover LD, Larson JD, Twarog N, et al. Abstract 6144: St. Jude Pediatric Brain Tumor Portal: Cloud-based resource for patient-derived orthotopic xenograft (PDOX) models of pediatric high-grade glioma, ependymoma, and CNS embryonal tumors Tumor Biology. DOI: 10.1158/1538-7445.Am2020-6144 |
0.447 |
|
| 2019 |
Silveira AB, Kasper LH, Fan Y, Jin H, Wu G, Shaw TI, Zhu X, Larson JD, Easton J, Shao Y, Yergeau DA, Rosencrance C, Boggs K, Rusch MC, Ding L, et al. H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo. Acta Neuropathologica. PMID 30770999 DOI: 10.1007/S00401-019-01975-4 |
0.453 |
|
| 2019 |
Beckmann PJ, Larson JD, Larsson AT, Ostergaard JP, Wagner S, Rahrmann EP, Shamsan GA, Otto GM, Williams RL, Wang J, Lee C, Tschida BR, Das P, Dubuc AM, Moriarity BS, et al. Sleeping Beauty insertional mutagenesis reveals important genetic drivers of central nervous system embryonal tumors. Cancer Research. PMID 30674530 DOI: 10.1158/0008-5472.Can-18-1261 |
0.728 |
|
| 2019 |
Larson JD, Baker SJ. Engineering Inducible Knock-In Mice to Model Oncogenic Brain Tumor Mutations from Endogenous Loci. Methods in Molecular Biology (Clifton, N.J.). 1869: 207-230. PMID 30324526 DOI: 10.1007/978-1-4939-8805-1_18 |
0.443 |
|
| 2019 |
Pribyl LJ, Downing SM, Camacho CV, Larson JD, Baker SJ, McKinnon PJ. Abstract LB-289: Genomic instability and the development of high-grade gliomas Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Lb-289 |
0.376 |
|
| 2019 |
Beckmann P, Krebs R, Larson J, Largaespada D. PDTM-19. MYC AND FAK/SRC COMBINATION TREATMENT OF FOXR2-HIGH BRAIN TUMORS Neuro-Oncology. 21: vi191-vi191. DOI: 10.1093/Neuonc/Noz175.795 |
0.647 |
|
| 2018 |
Larson JD, Kasper LH, Paugh BS, Jin H, Wu G, Kwon CH, Fan Y, Shaw TI, Silveira AB, Qu C, Xu R, Zhu X, Zhang J, Russell HR, Peters JL, et al. Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression. Cancer Cell. PMID 30595505 DOI: 10.1016/J.Ccell.2018.11.015 |
0.426 |
|
| 2018 |
Camilleri ET, Beckmann PJ, Larson JD, Kurata M, Shu J, Pope E, Hudson WA, Temiz NA, Rathe SK, LaRue RS, Sarver AE, Scott MC, Varshney J, Modiano JF, Moriarity BS, et al. Abstract 2264: RNA sequencing based analysis of transposon-induced tumors reveals novel insights into cancer pathogenesis and progression Cancer Research. 78: 2264-2264. DOI: 10.1158/1538-7445.Am2018-2264 |
0.738 |
|
| 2018 |
Beckmann P, Larson J, Larsson A, Ostergaard J, Largaespada D. CSIG-37. FOXR2 STABILIZES MYC AND ACTIVATES FAK/SRC SIGNALING IN A DUAL MECHANISM TO PROMOTE TRANSFORMATION IN NEURAL PROGENITOR CELLS Neuro-Oncology. 20: vi51-vi51. DOI: 10.1093/Neuonc/Noy148.203 |
0.496 |
|
| 2016 |
Zhu G, Rankin SL, Larson JD, Zhu X, Chow LM, Qu C, Zhang J, Ellison DW, Baker SJ. PTEN signaling in the postnatal perivascular progenitor niche drives medulloblastoma formation. Cancer Research. PMID 27815386 DOI: 10.1158/0008-5472.Can-16-1991 |
0.473 |
|
| 2016 |
Larson JD, Silveira AB, Kasper LH, Diaz AK, Zhu X, Baker SJ. Abstract IA15: The unique genomic and epigenomic landscape of pediatric high-grade glioma Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Devbiolca15-Ia15 |
0.357 |
|
| 2016 |
Larson JD, Kasper LH, Russell HR, Qu C, Zhu X, McKinnon PJ, Baker SJ. Abstract B01: Biological consequences of histone mutations in the mammalian brain Cancer Research. 76. DOI: 10.1158/1538-7445.Chromepi15-B01 |
0.432 |
|
| 2015 |
Heltemes-Harris LM, Larson JD, Starr TK, Hubbard GK, Sarver AL, Largaespada DA, Farrar MA. Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia. Oncogene. PMID 26500062 DOI: 10.1038/Onc.2015.405 |
0.568 |
|
| 2015 |
Larson JD, Silveira AB, Kasper LH, Russell HR, Qu C, McKinnon PJ, Baker SJ. Abstract IA14: The unique genomic landscape of pediatric high-grade glioma Brain. 75. DOI: 10.1158/1538-7445.Brain15-Ia14 |
0.421 |
|
| 2015 |
Larson J, Kasper L, Russell H, Qu C, Zhu X, McKinnon P, Baker S. PM-13 * BIOLOGICAL CONSEQUENCES OF HISTONE MUTATIONS IN THE MAMMALIAN BRAIN Neuro-Oncology. 17: iii34-iii34. DOI: 10.1093/Neuonc/Nov061.135 |
0.427 |
|
| 2014 |
Jackson P, Das P, Larson J, Moriarity B, Largaespada D. PM-05 * ARHGAP36 AS A NOVEL DRIVER IN HIGH-RISK HUMAN MEDULLOBLASTOMA Neuro-Oncology. 16: v170-v170. DOI: 10.1093/Neuonc/Nou268.5 |
0.702 |
|
| 2013 |
Larson JD, McEachron TA, Qu C, Zhu X, Diaz AK, Ellison DW, Orr BA, Baker SJ. Abstract A15: Variant histone H3 mutations associate with histone modification, DNA methylation, and gene expression changes in pediatric high-grade gliomas Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-A15 |
0.352 |
|
| 2013 |
Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Larson JD, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174 |
0.626 |
|
| 2012 |
Larson JD, Largaespada DA. Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions. In Vivo (Athens, Greece). 26: 487-500. PMID 22773561 |
0.598 |
|
| 2012 |
Bedell VM, Person AD, Larson JD, McLoon A, Balciunas D, Clark KJ, Neff KI, Nelson KE, Bill BR, Schimmenti LA, Beiraghi S, Ekker SC. The lineage-specific gene ponzr1 is essential for zebrafish pronephric and pharyngeal arch development. Development (Cambridge, England). 139: 793-804. PMID 22274699 DOI: 10.1242/Dev.071720 |
0.322 |
|
| 2010 |
Bender AM, Collier LS, Rodriguez FJ, Tieu C, Larson JD, Halder C, Mahlum E, Kollmeyer TM, Akagi K, Sarkar G, Largaespada DA, Jenkins RB. Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer Research. 70: 3557-65. PMID 20388773 DOI: 10.1158/0008-5472.Can-09-4674 |
0.63 |
|
| 2010 |
Adhikari N, Basi DL, Townsend D, Rusch M, Mariash A, Mullegama S, Watson A, Larson J, Tan S, Lerman B, Esko JD, Selleck SB, Hall JL. Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling. Journal of Molecular and Cellular Cardiology. 49: 287-93. PMID 20206635 DOI: 10.1016/J.Yjmcc.2010.02.022 |
0.574 |
|
| 2009 |
Kalén M, Wallgard E, Asker N, Nasevicius A, Athley E, Billgren E, Larson JD, Wadman SA, Norseng E, Clark KJ, He L, Karlsson-Lindahl L, Häger AK, Weber H, Augustin H, et al. Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets. Chemistry & Biology. 16: 432-41. PMID 19389629 DOI: 10.1016/J.Chembiol.2009.02.010 |
0.344 |
|
| 2009 |
Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, Long C, Demorest ZL, Zamora EA, Low WC, SantaCruz K, Largaespada DA, Ohlfest JR. De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Research. 69: 431-9. PMID 19147555 DOI: 10.1158/0008-5472.Can-08-1800 |
0.74 |
|
| 2007 |
Robu ME, Larson JD, Nasevicius A, Beiraghi S, Brenner C, Farber SA, Ekker SC. p53 activation by knockdown technologies. Plos Genetics. 3: e78. PMID 17530925 DOI: 10.1371/Journal.Pgen.0030078 |
0.303 |
|
| 2006 |
Pickart MA, Klee EW, Nielsen AL, Sivasubbu S, Mendenhall EM, Bill BR, Chen E, Eckfeldt CE, Knowlton M, Robu ME, Larson JD, Deng Y, Schimmenti LA, Ellis LB, Verfaillie CM, et al. Genome-wide reverse genetics framework to identify novel functions of the vertebrate secretome. Plos One. 1: e104. PMID 17218990 DOI: 10.1371/Journal.Pone.0000104 |
0.329 |
|
| 2006 |
Chen E, Larson JD, Ekker SC. Functional analysis of zebrafish microfibril-associated glycoprotein-1 (Magp1) in vivo reveals roles for microfibrils in vascular development and function. Blood. 107: 4364-74. PMID 16469878 DOI: 10.1182/Blood-2005-02-0789 |
0.307 |
|
| 2004 |
Larson JD, Wadman SA, Chen E, Kerley L, Clark KJ, Eide M, Lippert S, Nasevicius A, Ekker SC, Hackett PB, Essner JJ. Expression of VE-cadherin in zebrafish embryos: a new tool to evaluate vascular development. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 231: 204-13. PMID 15305301 DOI: 10.1002/Dvdy.20102 |
0.305 |
|
| 2002 |
Sumanas S, Larson JD. Morpholino phosphorodiamidate oligonucleotides in zebrafish: a recipe for functional genomics? Briefings in Functional Genomics & Proteomics. 1: 239-56. PMID 15239891 DOI: 10.1093/Bfgp/1.3.239 |
0.32 |
|
| 2001 |
Ekker SC, Larson JD. Morphant technology in model developmental systems. Genesis (New York, N.Y. : 2000). 30: 89-93. PMID 11477681 DOI: 10.1002/Gene.1038 |
0.359 |
|
| 2000 |
Nasevicius A, Larson J, Ekker SC. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast (Chichester, England). 17: 294-301. PMID 11119306 DOI: 10.1002/1097-0061(200012)17:4<294::Aid-Yea54>3.0.Co;2-5 |
0.3 |
|
| Show low-probability matches. |